tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Aschoff, 91 are a BUY (88.35%), 8 are a HOLD (7.77%), 4 are a SELL (3.88%).
Analyst Jonathan Aschoff, carries an average stock price target met ratio of 37.44% that have a potential upside of 32.59% achieved within 119 days.
Jonathan Aschoff’s has documented 187 price targets and ratings displayed on 36 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on APVO, Aptevo Therapeutics at 23-Sep-2024.
Analyst best performing recommendations are on PBLA (PANBELA THERAPEUTICS).
The best stock recommendation documented was for PBLA (PANBELA THERAPEUTICS) at 12/18/2023. The price target of $25 was fulfilled within 1 day with a profit of $4.8 (23.76%) receiving and performance score of 237.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-May-2021
$205
$22.5 (12.33%)
4 years 9 months ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 23-Mar-2021
$173
$-9.5 (-5.21%)
$156
4 years 9 months 2 days ago
(03-May-2021)
14/24 (58.33%)
$2.73 (1.60%)
682
Hold Since 14-Dec-2020
$190
4 years 9 months 10 days ago
(26-Apr-2021)
9/11 (81.82%)
$34.41 (22.12%)
350
Buy Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
5 years 1 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Hold Since 04-Feb-2021
$166
$-16.5 (-9.04%)
$175
5 years 1 days ago
(04-Feb-2021)
23/23 (100%)
$10.41 (6.69%)
828
What Year was the first public recommendation made by Jonathan Aschoff?
